Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial
GIP-1s and GIPs are not appropriate for pregnant women and individuals with severe gastrointestinal conditions such as gastroparesis and inflammatory bowel disease
doi: 10.2337/dc07-0048
The international classification of headache disorders, 3rd edition
Back Marks, V, Samols, E (1970) 'Intestinal factors in the regulation of insulin secretion', Advanced Metabolic Disorders , 4, 1-38
However, no single GLP-1 is definitively 'easiest' for everyone, and careful dose titration alongside dietary adjustments can significantly improve tolerability across all agents
US$ 25.73
US$ 29.67
US$ 21.28
US$ 24.49
US$ 27.33
